Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Xenon Pharmaceuticals Inc (NASDAQ: XENE) was $41.85 for the day, up 0.46% from the previous closing price of $41.66. In other words, the price has increased by $0.46 from its previous closing price. On the day, 0.53 million shares were traded. XENE stock price reached its highest trading level at $42.655 during the session, while it also had its lowest trading level at $41.66.
Ratios:
Our analysis of XENE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 23.27 and its Current Ratio is at 23.27. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On October 01, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $53.
On January 04, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $62.Citigroup initiated its Buy rating on January 04, 2024, with a $62 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 08 ’24 when GAROFALO ELIZABETH A. sold 2,092 shares for $45.69 per share. The transaction valued at 95,583 led to the insider holds 0 shares of the business.
ROBIN SHERRINGTON sold 7,137 shares of XENE for $330,290 on Mar 07 ’24. The EVP, Strategy & Innovation now owns 8,398 shares after completing the transaction at $46.28 per share. On Mar 07 ’24, another insider, GANNON STEVEN, who serves as the Director of the company, sold 13,000 shares for $46.28 each. As a result, the insider received 601,615 and left with 2,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XENE now has a Market Capitalization of 3170744064 and an Enterprise Value of 2459242496.
Stock Price History:
Over the past 52 weeks, XENE has reached a high of $50.99, while it has fallen to a 52-week low of $27.99. The 50-Day Moving Average of the stock is 3.90%, while the 200-Day Moving Average is calculated to be -0.08%.
Shares Statistics:
XENE traded an average of 344.66K shares per day over the past three months and 364120 shares per day over the past ten days. A total of 75.37M shares are outstanding, with a floating share count of 73.82M. Insiders hold about 2.56% of the company’s shares, while institutions hold 96.60% stake in the company. Shares short for XENE as of 1727654400 were 3301156 with a Short Ratio of 9.58, compared to 1724976000 on 3569456. Therefore, it implies a Short% of Shares Outstanding of 3301156 and a Short% of Float of 4.3899998.
